Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
The Impact of Direct-to-Consumer Advertising on Outpatient Care Utilization
Neeraj Sood and colleagues inform the debate about direct-to-consumer advertising by analyzing the effects of ads on office visits and treatment courses for five common chronic conditions.
Categorized in -
Does the Market Reward Quality? Evidence from India
The study provides insight into at what drives quality of care in the private sector and why patients seek care from poor quality providers.
Categorized in -
New Dialysis Studies Inform Delivery of Care, Ways to Improve Patient Outcomes
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
Categorized in -
During the Height of the Opioid Epidemic, the Out-of-Pocket Price of Naloxone Increased by Over 500%
A jump in the out-of-pocket price of naloxone has likely made the lifesaving drug too expensive for most uninsured Americans.
Categorized in -
Traditional Vaccination Playbook Doesn’t Work with COVID
New study finds financial incentives and other behavioral nudges made little difference among certain groups.
Categorized in -
Association of Fatal Overdose Notification Letters With Prescription of Benzodiazepines
New research builds on a landmark USC Schaeffer Center study aimed at reducing opioid overprescribing.
Categorized in -
‘Nudges’ to Reduce Opioid Overuse Also Decrease Inappropriate Benzodiazepine Prescriptions
Informing physicians when a patient dies of an overdose may provide the needed “nudge” to improve prescribing practices.
Categorized in -
Development and Pilot Testing of EHR-Nudges to Reduce Overuse in Older Primary Care Patients
Unnecessary testing and treatment of common conditions in older adults can lead to significant morbidity and mortality.
Categorized in -
Characterization of Cannabis Products Purchased for Medical Use in New York State
Schaeffer Center researchers analyzed point-of-sale data from nearly 17,000 medical cannabis patients making 80,000 purchases.
Categorized in -
Patient Preference for Medical Cannabis Products in the Absence of Clinical Guidelines
New analysis of New York data finds considerable variability in patient product choice, even for patients with the same condition.
Categorized in